Want to monitor Patent Applications? Get a free weekly report!

Jump to content

Synthetic Biology Patent Application Trends 2024: Difference between revisions

From WikiPatents
← Older edit
Updating Synthetic Biology Patent Application Trends 2024
Updating Synthetic Biology Patent Application Trends 2024
 
Line 1: Line 1:
== Synthetic Biology Patent Application Filing Activity ==
== Synthetic Biology Patent Application Filing Activity ==
== Synthetic Biology patent applications in 2024 ==
== Synthetic Biology patent applications in 2025 ==
[[File:Synthetic_Biology_Monthly_Patent_Applications_2024_-_Up_to_November 2024.png|border|800px]]
[[File:Synthetic_Biology_Monthly_Patent_Applications_2025_-_Up_to_ 2025.png|border|800px]]


== Top Technology Areas in Synthetic Biology ==
== Top Technology Areas in Synthetic Biology ==
[[File:Top_Technology_Areas_in_Synthetic_Biology_2024_-_Up_to_November 2024.png|border|800px]]
[[File:Top_Technology_Areas_in_Synthetic_Biology_2025_-_Up_to_ 2025.png|border|800px]]


=== Top CPC Codes ===
=== Top CPC Codes ===
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
** Count: 102 patents
** Count: 111 patents
** Example: [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]]
** Example: [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]]
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
** Count: 96 patents
** Count: 106 patents
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
** Count: 46 patents
** Count: 53 patents
** Example: [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]]
** Example: [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]]
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
** Count: 34 patents
** Count: 38 patents
** Example: [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]]
** Example: [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]]
* [[:Category:CPC_C12N2800/80|C12N2800/80]] (No explanation available)
** Count: 30 patents
** Example: [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]]
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
** Count: 29 patents
** Example: [[20240229024. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]]
* [[:Category:CPC_C12N15/102|C12N15/102]] (No explanation available)
* [[:Category:CPC_C12N15/102|C12N15/102]] (No explanation available)
** Count: 27 patents
** Count: 28 patents
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
** Count: 27 patents
** Count: 20 patents
** Example: [[20240229024. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]]
** Example: [[20240424138. GENOME EDITING COMPOSITIONS AND METHOD FOR TREATMENT OF RETINITIS PIGMENTOSA (Prime Medicine, Inc.)]]
* [[:Category:CPC_C12N2800/80|C12N2800/80]] (No explanation available)
** Count: 27 patents
** Example: [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]]
* [[:Category:CPC_C12N15/113|C12N15/113]] (No explanation available)
* [[:Category:CPC_C12N15/113|C12N15/113]] (No explanation available)
** Count: 18 patents
** Count: 19 patents
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
** Count: 17 patents
** Example: [[20240350666. COMPOSITIONS AND METHODS FOR HIGH EFFICIENCY GENOME EDITING (Children`s Medical Center Corporation)]]
* [[:Category:CPC_C12N15/63|C12N15/63]] (No explanation available)
* [[:Category:CPC_C12N15/63|C12N15/63]] (No explanation available)
** Count: 14 patents
** Count: 14 patents
Line 42: Line 42:


=== [[:Category:INBIOSE N.V.|INBIOSE N.V.]] ===
=== [[:Category:INBIOSE N.V.|INBIOSE N.V.]] ===
* Number of Synthetic Biology patents: 9
* Number of Synthetic Biology patents: 11
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/1051|C12N9/1051]] (No explanation available): 7 patents
** [[:Category:CPC_C12N9/1081|C12N9/1081]] (No explanation available): 5 patents
** [[:Category:CPC_C12N9/1081|C12N9/1081]] (No explanation available): 5 patents
** [[:Category:CPC_C12P19/12|C12P19/12]] (No explanation available): 5 patents
** [[:Category:CPC_C12P19/12|C12P19/12]] (No explanation available): 5 patents
** [[:Category:CPC_C12N9/1051|C12N9/1051]] (No explanation available): 5 patents
* Recent patents:
* Recent patents:
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
Line 71: Line 71:
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
** [[20240033355. ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS (Fate Therapeutics, Inc.)]] (20240201)
** [[20240033355. ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS (Fate Therapeutics, Inc.)]] (20240201)
=== [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]] ===
* Number of Synthetic Biology patents: 5
* Top CPC codes:
** [[:Category:CPC_C12N9/1276|C12N9/1276]] (No explanation available): 4 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 4 patents
** [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available): 4 patents
* Recent patents:
** [[20240117382. DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs) (The Broad Institute, Inc.)]] (20240411)
** [[20240158779. METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE (The Broad Institute, Inc.)]] (20240516)
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
=== [[:Category:UNIVERSITY OF MASSACHUSETTS|UNIVERSITY OF MASSACHUSETTS]] ===
* Number of Synthetic Biology patents: 5
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 4 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 4 patents
** [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available): 3 patents
* Recent patents:
** [[20240141359. GENOME EDITING FOR TREATING MUSCULAR DYSTROPHY (UNIVERSITY OF MASSACHUSETTS)]] (20240502)
** [[20240167029. MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING (UNIVERSITY OF MASSACHUSETTS)]] (20240523)
** [[20240036027. Nanopore Biosensors and Uses Thereof (UNIVERSITY OF MASSACHUSETTS)]] (20240201)
=== [[:Category:PRIME MEDICINE, INC.|PRIME MEDICINE, INC.]] ===
=== [[:Category:PRIME MEDICINE, INC.|PRIME MEDICINE, INC.]] ===
* Number of Synthetic Biology patents: 4
* Number of Synthetic Biology patents: 4
Line 81: Line 101:
** [[20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS (PRIME MEDICINE, INC.)]] (20240912)
** [[20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS (PRIME MEDICINE, INC.)]] (20240912)
** [[20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240523)
** [[20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240523)
=== [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]] ===
=== [[:Category:Prime Medicine, Inc.|Prime Medicine, Inc.]] ===
* Number of Synthetic Biology patents: 4
* Number of Synthetic Biology patents: 4
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available): 4 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 4 patents
** [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available): 3 patents
** [[:Category:CPC_C12N9/1276|C12N9/1276]] (No explanation available): 3 patents
** [[:Category:CPC_C12N9/1276|C12N9/1276]] (No explanation available): 3 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 3 patents
* Recent patents:
* Recent patents:
** [[20240117382. DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs) (The Broad Institute, Inc.)]] (20240411)
** [[20240352453. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF RETINOPATHY (Prime Medicine, Inc.)]] (20241024)
** [[20240158779. METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE (The Broad Institute, Inc.)]] (20240516)
** [[20240376466. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF FANCONI ANEMIA (Prime Medicine, Inc.)]] (20241114)
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
** [[20240360476. Genome Editing Compositions and Methods for Treatment of Myotonic Dystrophy (Prime Medicine, Inc.)]] (20241031)
=== [[:Category:Massachusetts Institute of Technology|Massachusetts Institute of Technology]] ===
=== [[:Category:Massachusetts Institute of Technology|Massachusetts Institute of Technology]] ===
* Number of Synthetic Biology patents: 4
* Number of Synthetic Biology patents: 4
Line 111: Line 131:
** [[20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction (The Board of Trustees of the Leland Stanford Junior University)]] (20241205)
** [[20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction (The Board of Trustees of the Leland Stanford Junior University)]] (20241205)
** [[20240018493. KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION (The Board of Trustees of the Leland Stanford Junior University)]] (20240118)
** [[20240018493. KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION (The Board of Trustees of the Leland Stanford Junior University)]] (20240118)
=== [[:Category:UNIVERSITY OF MASSACHUSETTS|UNIVERSITY OF MASSACHUSETTS]] ===
* Number of Synthetic Biology patents: 4
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available): 2 patents
* Recent patents:
** [[20240141359. GENOME EDITING FOR TREATING MUSCULAR DYSTROPHY (UNIVERSITY OF MASSACHUSETTS)]] (20240502)
** [[20240167029. MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING (UNIVERSITY OF MASSACHUSETTS)]] (20240523)
** [[20240036027. Nanopore Biosensors and Uses Thereof (UNIVERSITY OF MASSACHUSETTS)]] (20240201)
=== [[:Category:Wisconsin Alumni Research Foundation|Wisconsin Alumni Research Foundation]] ===
=== [[:Category:Wisconsin Alumni Research Foundation|Wisconsin Alumni Research Foundation]] ===
* Number of Synthetic Biology patents: 3
* Number of Synthetic Biology patents: 3
Line 131: Line 141:
** [[20240131066. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]] (20240425)
** [[20240131066. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]] (20240425)
** [[20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME (Wisconsin Alumni Research Foundation)]] (20240125)
** [[20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME (Wisconsin Alumni Research Foundation)]] (20240125)
=== [[:Category:Prime Medicine, Inc.|Prime Medicine, Inc.]] ===
* Number of Synthetic Biology patents: 3
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_C12N9/1276|C12N9/1276]] (No explanation available): 2 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 2 patents
* Recent patents:
** [[20240352453. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF RETINOPATHY (Prime Medicine, Inc.)]] (20241024)
** [[20240376466. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF FANCONI ANEMIA (Prime Medicine, Inc.)]] (20241114)
** [[20240360476. Genome Editing Compositions and Methods for Treatment of Myotonic Dystrophy (Prime Medicine, Inc.)]] (20241031)


== New Companies in Synthetic Biology (Last Month) ==
== New Companies in Synthetic Biology (Last Month) ==
Line 194: Line 194:


=== [[:Category:Joeri Beauprez|Joeri Beauprez]] ===
=== [[:Category:Joeri Beauprez|Joeri Beauprez]] ===
* Number of Synthetic Biology patents: 9
* Number of Synthetic Biology patents: 11
* Top companies:
* Top companies:
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 9 patents
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 11 patents
* Recent patents:
* Recent patents:
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
** [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240314)
** [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240314)
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
=== [[:Category:Annelies Vercauteren|Annelies Vercauteren]] ===
* Number of Synthetic Biology patents: 7
* Top companies:
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 7 patents
* Recent patents:
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
** [[20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES (INBIOSE N.V.)]] (20240201)
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
=== [[:Category:Bahram VALAMEHR|Bahram VALAMEHR of San Diego CA (US)]] ===
=== [[:Category:Bahram VALAMEHR|Bahram VALAMEHR of San Diego CA (US)]] ===
Line 210: Line 218:
** [[20240033355. ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS (Fate Therapeutics, Inc.)]] (20240201)
** [[20240033355. ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS (Fate Therapeutics, Inc.)]] (20240201)
=== [[:Category:David R. Liu|David R. Liu of Cambridge MA (US)]] ===
=== [[:Category:David R. Liu|David R. Liu of Cambridge MA (US)]] ===
* Number of Synthetic Biology patents: 5
* Number of Synthetic Biology patents: 6
* Top companies:
* Top companies:
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 3 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 4 patents
** [[:Category:President and Fellows of Harvard College|President and Fellows of Harvard College]]: 2 patents
** [[:Category:President and Fellows of Harvard College|President and Fellows of Harvard College]]: 2 patents
* Recent patents:
* Recent patents:
Line 218: Line 226:
** [[20240209329. PROGRAMMABLE CAS9-RECOMBINASE FUSION PROTEINS AND USES THEREOF (President and Fellows of Harvard College)]] (20240627)
** [[20240209329. PROGRAMMABLE CAS9-RECOMBINASE FUSION PROTEINS AND USES THEREOF (President and Fellows of Harvard College)]] (20240627)
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
=== [[:Category:Kristof Vandewalle|Kristof Vandewalle]] ===
* Number of Synthetic Biology patents: 6
* Top companies:
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 6 patents
* Recent patents:
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
** [[20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES (INBIOSE N.V.)]] (20240201)
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
=== [[:Category:Pieter Coussement|Pieter Coussement]] ===
=== [[:Category:Pieter Coussement|Pieter Coussement]] ===
* Number of Synthetic Biology patents: 5
* Number of Synthetic Biology patents: 5
Line 234: Line 250:
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
=== [[:Category:Annelies Vercauteren|Annelies Vercauteren]] ===
* Number of Synthetic Biology patents: 5
* Top companies:
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 5 patents
* Recent patents:
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
** [[20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES (INBIOSE N.V.)]] (20240201)
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
=== [[:Category:Ryan BJORDAHL|Ryan BJORDAHL of San Diego CA (US)]] ===
=== [[:Category:Ryan BJORDAHL|Ryan BJORDAHL of San Diego CA (US)]] ===
* Number of Synthetic Biology patents: 4
* Number of Synthetic Biology patents: 4
Line 258: Line 266:
** [[20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES (Fate Therapeutics, Inc.)]] (20240919)
** [[20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES (Fate Therapeutics, Inc.)]] (20240919)
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
=== [[:Category:Kristof Vandewalle|Kristof Vandewalle]] ===
=== [[:Category:Andrew Vito Anzalone|Andrew Vito Anzalone of Cambridge MA (US)]] ===
* Number of Synthetic Biology patents: 4
* Number of Synthetic Biology patents: 4
* Top companies:
* Top companies:
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 4 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 4 patents
* Recent patents:
* Recent patents:
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
** [[20240417753. METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241219)
** [[20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES (INBIOSE N.V.)]] (20240201)
** [[20240158779. METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE (The Broad Institute, Inc.)]] (20240516)
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
=== [[:Category:Tom Tong LEE|Tom Tong LEE of San Diego CA (US)]] ===
=== [[:Category:Tom Tong LEE|Tom Tong LEE of San Diego CA (US)]] ===
* Number of Synthetic Biology patents: 3
* Number of Synthetic Biology patents: 3
Line 291: Line 299:
** [[20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS (PRIME MEDICINE, INC.)]] (20240912)
** [[20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS (PRIME MEDICINE, INC.)]] (20240912)
** [[20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240523)
** [[20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240523)
=== [[:Category:Andrew Vito Anzalone|Andrew Vito Anzalone of Cambridge MA (US)]] ===
* Number of Synthetic Biology patents: 3
* Top companies:
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 3 patents
* Recent patents:
** [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20240711)
** [[20240158779. METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE (The Broad Institute, Inc.)]] (20240516)
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
=== [[:Category:Roman Lvovitch BOGORAD|Roman Lvovitch BOGORAD of South Boston MA (US)]] ===
=== [[:Category:Roman Lvovitch BOGORAD|Roman Lvovitch BOGORAD of South Boston MA (US)]] ===
* Number of Synthetic Biology patents: 3
* Number of Synthetic Biology patents: 3
Line 308: Line 308:
** [[20240175014. MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (CRISPR Therapeutics AG)]] (20240530)
** [[20240175014. MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (CRISPR Therapeutics AG)]] (20240530)
** [[20240167060. COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR POLYNUCLEOTIDES (CRISPR Therapeutics AG)]] (20240523)
** [[20240167060. COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR POLYNUCLEOTIDES (CRISPR Therapeutics AG)]] (20240523)
=== [[:Category:Wolfgang HINZ|Wolfgang HINZ of Killingworth CT (US)]] ===
* Number of Synthetic Biology patents: 3
* Top companies:
** [[:Category:LIFE TECHNOLOGIES CORPORATION|LIFE TECHNOLOGIES CORPORATION]]: 2 patents
** [[:Category:Life Technologies Corporation|Life Technologies Corporation]]: 1 patents
* Recent patents:
** [[20240426775. METHODS AND APPARATUS FOR MEASURING ANALYTES USING LARGE SCALE FET ARRAYS (Life Technologies Corporation)]] (20241226)
** [[20240159702. METHODS AND APPARATUS FOR MEASURING ANALYTES USING LARGE SCALE FET ARRAYS (LIFE TECHNOLOGIES CORPORATION)]] (20240516)
** [[20240309443. Surface Stabilization of Biosensors (LIFE TECHNOLOGIES CORPORATION)]] (20240919)
=== [[:Category:Dewi HARJANTO|Dewi HARJANTO of Brookline MA (US)]] ===
=== [[:Category:Dewi HARJANTO|Dewi HARJANTO of Brookline MA (US)]] ===
* Number of Synthetic Biology patents: 3
* Number of Synthetic Biology patents: 3
Line 452: Line 461:
** [[20240229078. MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A (CRISPR THERAPEUTICS AG)]] (20240711)
** [[20240229078. MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A (CRISPR THERAPEUTICS AG)]] (20240711)
** [[20240175014. MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (CRISPR Therapeutics AG)]] (20240530)
** [[20240175014. MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (CRISPR Therapeutics AG)]] (20240530)
=== [[:Category:Tianwei Tan|Tianwei Tan]] ===
* Number of Synthetic Biology patents: 2
* Top companies:
** [[:Category:Beijing University of Chemical Technology|Beijing University of Chemical Technology]]: 2 patents
* Recent patents:
** [[20240425889. GENETIC ENGINEERING BACTERIUM FOR DE NOVO SYNTHESIS OF CIS,CIS-MUCONIC ACID BY TAKING GLUCOSE AS SUBSTRATE AND APPLICATIONS THEREOF (Beijing University of Chemical Technology)]] (20241226)
** [[20240318209. GENETICALLY ENGINEERED BACTERIUM USING GLUCOSE AS SUBSTRATE FOR DE NOVO SYNTHESIS OF VANILLIN AND APPLICATION THEREOF (Beijing University of Chemical Technology)]] (20240926)
=== [[:Category:James BUSTILLO|James BUSTILLO of Castro Valley CA (US)]] ===
* Number of Synthetic Biology patents: 2
* Top companies:
** [[:Category:Life Technologies Corporation|Life Technologies Corporation]]: 1 patents
** [[:Category:LIFE TECHNOLOGIES CORPORATION|LIFE TECHNOLOGIES CORPORATION]]: 1 patents
* Recent patents:
** [[20240426775. METHODS AND APPARATUS FOR MEASURING ANALYTES USING LARGE SCALE FET ARRAYS (Life Technologies Corporation)]] (20241226)
** [[20240159702. METHODS AND APPARATUS FOR MEASURING ANALYTES USING LARGE SCALE FET ARRAYS (LIFE TECHNOLOGIES CORPORATION)]] (20240516)
=== [[:Category:Rasmus O. Bak|Rasmus O. Bak of Stanford CA (US)]] ===
=== [[:Category:Rasmus O. Bak|Rasmus O. Bak of Stanford CA (US)]] ===
* Number of Synthetic Biology patents: 2
* Number of Synthetic Biology patents: 2
Line 550: Line 574:
** [[20240287165. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240829)
** [[20240287165. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240829)
** [[20240301044. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240912)
** [[20240301044. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240912)
=== [[:Category:Eric Reiman|Eric Reiman of Phoenix AZ (US)]] ===
* Number of Synthetic Biology patents: 2
* Top companies:
** [[:Category:The General Hospital Corporation|The General Hospital Corporation]]: 2 patents
* Recent patents:
** [[20240287165. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240829)
** [[20240301044. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240912)
=== [[:Category:Francisco Lopera|Francisco Lopera]] ===
* Number of Synthetic Biology patents: 2
* Top companies:
** [[:Category:The General Hospital Corporation|The General Hospital Corporation]]: 2 patents
* Recent patents:
** [[20240287165. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240829)
** [[20240301044. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240912)
=== [[:Category:Radwanul Hasan SIDDIQUE|Radwanul Hasan SIDDIQUE of Monrovia CA (US)]] ===
* Number of Synthetic Biology patents: 2
* Top companies:
** [[:Category:Samsung Electronics Co., Ltd.|Samsung Electronics Co., Ltd.]]: 2 patents
* Recent patents:
** [[20240350024. POLARIZED PHOTOPLETHYSMOGRAPHY (PPG) BIOSENSORS, ARRAYS AND SYSTEMS (Samsung Electronics Co., Ltd.)]] (20241024)
** [[20240065566. POLARIZED PHOTOPLETHYSMOGRAPHY (PPG) BIOSENSORS, ARRAYS AND SYSTEMS (Samsung Electronics Co., Ltd.)]] (20240229)


== Top Collaborations in Synthetic Biology ==
== Top Collaborations in Synthetic Biology ==
Line 582: Line 585:
[[File:Top_20_Cities_for_Synthetic_Biology_Inventors.png|border|800px]]
[[File:Top_20_Cities_for_Synthetic_Biology_Inventors.png|border|800px]]


* Cambridge: 81 inventors
* Cambridge: 85 inventors
* Zwijnaarde: 43 inventors
* Zwijnaarde: 49 inventors
* San Diego: 37 inventors
* San Diego: 38 inventors
* Beijing: 18 inventors
* Beijing: 20 inventors
* Boston: 19 inventors
* South Boston: 18 inventors
* South Boston: 18 inventors
* Boston: 16 inventors
* Seoul: 16 inventors
* Seoul: 16 inventors
* Wuhan: 15 inventors
* Wuhan: 15 inventors
Line 596: Line 599:
* Irvine: 10 inventors
* Irvine: 10 inventors
* Durham: 10 inventors
* Durham: 10 inventors
* Brookline: 9 inventors
* Raleigh: 8 inventors
* Raleigh: 8 inventors
* Brookline: 8 inventors
* Burlington: 8 inventors
* Burlington: 8 inventors
* Madison: 7 inventors
* Madison: 7 inventors
* Alameda: 7 inventors
* Alameda: 7 inventors
* Boise: 7 inventors
* Pittsburgh: 7 inventors


[[Category:Synthetic Biology]]
[[Category:Synthetic Biology]]
[[Category:Patent Application Trends by Technology in 2024]]
[[Category:Patent Application Trends by Technology in 2024]]

Latest revision as of 08:07, 3 January 2025

Synthetic Biology Patent Application Filing Activity

Synthetic Biology patent applications in 2025

Error creating thumbnail: File missing

Top Technology Areas in Synthetic Biology

Top CPC Codes

Top Companies in Synthetic Biology

INBIOSE N.V.

The General Hospital Corporation

Fate Therapeutics, Inc.

The Broad Institute, Inc.

UNIVERSITY OF MASSACHUSETTS

PRIME MEDICINE, INC.

Prime Medicine, Inc.

Massachusetts Institute of Technology

The Board of Trustees of the Leland Stanford Junior University

Wisconsin Alumni Research Foundation

New Companies in Synthetic Biology (Last Month)

File:New Companies in Synthetic Biology Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Synthetic Biology

Top Companies in Emerging Synthetic Biology Technologies

Error creating thumbnail: File missing

Top Inventors in Synthetic Biology

Joeri Beauprez

Annelies Vercauteren

Bahram VALAMEHR of San Diego CA (US)

David R. Liu of Cambridge MA (US)

Kristof Vandewalle

Pieter Coussement

Thomas Decoene

Ryan BJORDAHL of San Diego CA (US)

Jode GOODRIDGE of San Diego CA (US)

Andrew Vito Anzalone of Cambridge MA (US)

Tom Tong LEE of San Diego CA (US)

Wei Hsi YEH of Cambridge MA (US)

Aaron Nakwon CHANG of Lexington MA (US)

Roman Lvovitch BOGORAD of South Boston MA (US)

Wolfgang HINZ of Killingworth CT (US)

Dewi HARJANTO of Brookline MA (US)

Sofie Aesaert

Gert Peters

Jin-Soo Kim

Seung Woo Cho

Sojung Kim

Krishanu Saha of Madison WI (US)

Lauren Sarko of Middleton WI (US)

Ante Sven Lundberg of Cambridge MA (US)

Chase Lawrence Beisel of Raleigh NC (US)

Scott Patrick Collins of Raleigh NC (US)

David Baram

Lior Izhar

Rafi Emmanuel

Jonathan M. LEVY of Brookline MA (US)

Yuan WANG

James William Nelson of Cambridge MA (US)

Chad Albert COWAN of South Boston MA (US)

Ante Sven LUNDBERG of South Boston MA (US)

Tianwei Tan

James BUSTILLO of Castro Valley CA (US)

Rasmus O. Bak of Stanford CA (US)

Ayal Hendel of Stanford CA (US)

Matthew H. Porteus of Stanford CA (US)

Michael Andreas Kock

Michael Lee Nuccio of Salem NH (US)

Frédéric Van Ex

Alexandra Elata of Arlington MA (US)

Daniel Rodriguez Leal of Raleigh NC (US)

Joshua L. Price of Cambridge MA (US)

Sofie De Maeseneire

Yatti De Nijs

Tom Delmulle

Yakeel T. Quiroz of Charlestown MA (US)

Joseph F. Arboleda-Velasquez of Newton MA (US)

Top Collaborations in Synthetic Biology

Top US States for Synthetic Biology Inventors

Error creating thumbnail: File missing


Top Cities for Synthetic Biology Inventors

  • Cambridge: 85 inventors
  • Zwijnaarde: 49 inventors
  • San Diego: 38 inventors
  • Beijing: 20 inventors
  • Boston: 19 inventors
  • South Boston: 18 inventors
  • Seoul: 16 inventors
  • Wuhan: 15 inventors
  • Stanford: 14 inventors
  • Seattle: 14 inventors
  • San Francisco: 13 inventors
  • Chicago: 10 inventors
  • Irvine: 10 inventors
  • Durham: 10 inventors
  • Brookline: 9 inventors
  • Raleigh: 8 inventors
  • Burlington: 8 inventors
  • Madison: 7 inventors
  • Alameda: 7 inventors
  • Pittsburgh: 7 inventors
Retrieved from "http://wikipatents.org/index.php?title=Synthetic_Biology_Patent_Application_Trends_2024&oldid=276373"